Jaguar Health, Inc.
JAGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $2 | $4 |
| % Growth | 3.5% | 34.6% | -36.9% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $2 | $2 | $2 | $3 |
| % Margin | 64.6% | 82.3% | 76.7% | 84.1% |
| R&D Expenses | $4 | $3 | $4 | $5 |
| G&A Expenses | $0 | $6 | $6 | $5 |
| SG&A Expenses | $6 | $7 | $7 | $7 |
| Sales & Mktg Exp. | $0 | $1 | $1 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $10 | $11 | $11 |
| Operating Income | -$7 | -$8 | -$9 | -$8 |
| % Margin | -234.8% | -268.8% | -425.5% | -232.5% |
| Other Income/Exp. Net | -$2 | -$3 | -$1 | -$2 |
| Pre-Tax Income | -$10 | -$11 | -$11 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$10 | -$10 | -$10 |
| % Margin | -308.2% | -349.3% | -472.6% | -282.7% |
| EPS | -6.28 | -10.26 | -16.7 | -33.68 |
| % Growth | 38.8% | 38.6% | 50.4% | – |
| EPS Diluted | -6.28 | -10.26 | -16.7 | -33.68 |
| Weighted Avg Shares Out | 2 | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | 2 | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$9 | -$7 | -$9 | -$16 |
| % Margin | -294.6% | -250.1% | -400.9% | -448.9% |